© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
iRhythm Technologies, Inc. (IRTC) stock surged +5.19%, trading at $110.12 on NASDAQ, up from the previous close of $104.69. The stock opened at $107.70, fluctuating between $104.38 and $112.56 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 22, 2026 | 104.85 | 105.44 | 102.02 | 104.69 | 303.95K |
| Jun 18, 2026 | 101.79 | 105.05 | 100.85 | 104.65 | 626.32K |
| Jun 17, 2026 | 107.85 | 108.16 | 101.10 | 101.79 | 1.24M |
| Jun 16, 2026 | 113.86 | 114.89 | 107.78 | 108.84 | 447.19K |
| Jun 15, 2026 | 114.64 | 115.32 | 112.39 | 113.76 | 204.57K |
| Jun 12, 2026 | 112.27 | 114.26 | 109.97 | 113.65 | 290.61K |
| Jun 11, 2026 | 113.87 | 114.75 | 110.21 | 112.67 | 354.02K |
| Jun 10, 2026 | 113.83 | 118.08 | 113.35 | 113.94 | 491.36K |
| Jun 09, 2026 | 108.06 | 114.20 | 107.80 | 113.83 | 583.4K |
| Jun 08, 2026 | 108.21 | 111.26 | 106.99 | 107.23 | 573.22K |
| Jun 05, 2026 | 109.00 | 109.59 | 106.12 | 108.11 | 556.01K |
| Jun 04, 2026 | 105.90 | 113.14 | 104.79 | 107.35 | 830.93K |
| Jun 03, 2026 | 105.28 | 108.95 | 101.75 | 104.56 | 637.25K |
| Jun 01, 2026 | 111.88 | 114.35 | 109.02 | 109.17 | 430.66K |
| May 29, 2026 | 115.61 | 117.41 | 113.62 | 113.90 | 320.22K |
| May 28, 2026 | 111.39 | 118.69 | 110.03 | 115.61 | 674.78K |
| May 27, 2026 | 115.11 | 115.11 | 108.95 | 111.39 | 768.69K |
| May 26, 2026 | 116.33 | 117.46 | 113.24 | 114.45 | 485.51K |
| May 22, 2026 | 118.09 | 123.15 | 112.86 | 116.56 | 462.96K |
| May 21, 2026 | 116.31 | 118.32 | 113.71 | 117.87 | 234.15K |
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
| Employees | 2000 |
| Beta | 1.28 |
| Sales or Revenue | $492.68M |
| 5Y Sales Change% | 1.617% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |